StockNews.AI
ZYXI
StockNews.AI
28 days

Zynex Sets Second Quarter 2025 Earnings Call

1. Zynex will hold a conference call on July 31, 2025. 2. Financial results for Q2 2025 will be discussed during the call. 3. Zynex specializes in non-invasive medical devices for pain management and rehabilitation. 4. The call will include a Q&A session with management. 5. Details for accessing the call will be provided in a press release.

Earnings
+3.52%Current Return
VS
+1.06%S&P 500
$2.41507/22 11:42 AM EDTEvent Start
$2.507/23 05:56 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Neutral?

While quarterly results are critical, the outcome is uncertain. Previous calls had mixed effects on ZYXI's stock price.

How important is it?

Earnings calls are integral for stock analysis but are routine events.

Why Short Term?

The conference call focuses on immediate financial results, with effects likely evident shortly after.

Related Companies

MEDTRONICBOSTON SCIENTIFIC
, /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, July 31, 2025 at 4:15 PM Eastern Time to discuss its financial results for the second quarter ended June 30, 2025.  Financial results will be issued in a press release prior to the call. Zynex management will host the conference call, followed by a question and answer session. Date: Thursday, July 31, 2025Time: 4:15 PM Eastern Time (2:15 PM Mountain Time)U.S. & Canada dial-in number: 800-836-8184International number: 646-357-8785Webcast: Q2-2025 Webcast Link The Company will also provide a link at https://zynexmed.investorroom.com/ for those who wish to stream the call via webcast. Please call the conference telephone number 5-10 minutes prior to the start time. About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com. Investor Relations Contact:Dan Moorhead, CFO[email protected] SOURCE Zynex, Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News